Search
Menu
Home
HTB
2015
July
July 2015
Contents
Special reports
HTB supplement: 2015 Pipeline Report
Pipeline report
Dedication
The antiretroviral pipeline 2015
Fit for purpose: antiretroviral treatment optimisation 2015
The Pediatric Antiretroviral Pipeline
Preventive Technologies: Antiretroviral and Vaccine Development
Research Toward a Cure and Immune-Based and Gene Therapies
New Drugs, New Strategies: Conquering Hepatitis C with Direct-Acting Antivirals
The Tuberculosis Treatment Pipeline: Moving Beyond “Making the Most of What We’ve Got”
Momentum in the Pediatric Tuberculosis Treatment Pipeline
The Tuberculosis Diagnostics Pipeline
The Tuberculosis Vaccines Pipeline: A New Path to the Same Destination?
HTB RSS
Early access
The RIO study: Q&A about controlling HIV with bNAbs
21 April 2025
Lenacapavir EAP in the UK closed to new referrals: NHS England and Gilead fail to agree a price after more than two years
20 April 2025
Viral failure on CAB/RPV-LA: overcoming drug resistance with second-generation INSTIs
13 April 2025
Lancet HIV recognises Transgender Day of Visibility and the importance of gender-affirming hormones in HIV care
3 April 2025
All early access reports
Current issues
April 2025
March 2025
February 2025
Back issues
Special report
Lancet HIV recognises Transgender Day of Visibility and the importance of gender-affirming hormones in HIV care
3 April 2025
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate